The Pivotal Role of the Primary Care Provider in Managing Patients With Cardiorenal Metabolic Diseases
The Nebraska Academy of Family Physicians (NE-AFP) cordially invites you to attend a CME/CE/ABIM MOC–certified live webinar titled, “The Pivotal Role of the Primary Care Provider in Managing Patients With Cardiorenal Metabolic Diseases.” This activity will improve the knowledge and competence of learners in effort to optimize treatment for patients with cardiorenal metabolic diseases.
Tuesday, November 14, 2023
Live Virtual Meeting
6:00 PM - 7:00 PM CT
For full accreditation information and to register, go to: https://clinicaloptions.com/CardiorenalManagement2023
Join us for a CME/CE/ABIM MOC–certified interactive, case-based discussion where experts in primary care, heart failure, and chronic kidney disease discuss the importance of integrating SGLT2 inhibitors into daily practice. Gain insight into the benefits of SGLT2 inhibitors beyond their use in type 2 diabetes, discuss clinical evidence for use in heart failure and chronic kidney disease, and implement strategies to mitigate adverse events while optimizing patient care.
- Ty Gluckman, MD, MHA, FACC, FAHA, FASPC
- Medical Director, Center for Cardiovascular Analytics, Research and Data Science (CARDS) Providence Heart Institute, Providence St. Joseph Health, Portland, Oregon
- Nayan Arora, MD
- Assistance Clinical Professor, Division of Nephrology, Clinical Lead of the Diabetic Kidney Clinic and Inpatient Cardiorenal Service, University of Washington, Seattle, Washington
- Kim Pfotenhauer, DO, FACOFP
- Assistant Professor, Assistant Dean for Clerkship Education, Michigan State University, College of Osteopathic Medicine, East Lansing, Michigan
- Introductions and polling
- Overview of cardiorenal metabolic disease
- Overview of SGLT2 inhibitors
- Case-based discussions highlighting guidelines and clinical evidence
- Closing and question and answer session
This program is intended for primary care physicians, PAs, NPs, and other healthcare professionals who manage patients with cardiorenal metabolic comorbidities.
Upon completion of this activity, learners should be able to:
- Assess the effects of SGLT2 inhibitors beyond glycemic management for patients with cardiorenal metabolic comorbidities.
- Integrate different SGLT2 inhibitors into the treatment for patients with diabetes, HF, and CKD based on clinical evidence and guideline recommendations.
- Implement strategies to collaboratively mitigate adverse effects and optimize access for patients with indications for SGLT2 inhibitors.
JOINT ACCREDITATION STATEMENT: In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION: CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CONTINUING PROFESSIONAL DEVELOPMENT: The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
PHYSICIAN ASSOCIATE/PHYSICIAN ASSISTANT CONTINUING MEDICAL EDUCATION: Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.
ABIM MOC RECOGNITION STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point and patient safety MOC credit in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through USFH’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).
Disclosures will be made known to learners before the activity.